Author

Jinxi Chang

h-index 0 View on Semantic Scholar

We have 1 of 2 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Jul 2026

Nanomaterials Drive In Vivo CAR Immune Cells Engineering.

The intrinsic trade-off between therapeutic durability and biosafety across distinct delivery platforms is discussed, along with the necessity that their clinical translation hinges on systematic optimization of delivery precision, immune compatibility, and expression controllability.

Meifen Luo, Kai Liao, Jinxi Chang et al. · Advances in Materials · 0 citations